Elos Medtech AB Series B | Cash Flow
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
41,636.00
31,808.00
22,528.00
37,927.00
26,405.00
28,477
Depreciation, Depletion & Amortization
40,562.00
34,720.00
48,773.00
54,631.00
51,290.00
55,419
Other Funds
4,338.00
8,832.00
2,813.00
-
-
7,981
Funds from Operations
82,057.00
61,432.00
62,386.00
91,058.00
82,454.00
75,915
Changes in Working Capital
5,225.00
6,178.00
781.00
7,225.00
20,357.00
9,876
Net Operating Cash Flow
87,282.00
55,254.00
61,605.00
98,283.00
62,097.00
66,039
Capital Expenditures
21,273.00
23,871.00
46,261.00
34,586.00
37,576.00
Sale of Fixed Assets & Businesses
932.00
206.00
135.00
5,245.00
-
Purchase/Sale of Investments
20.00
-
-
17.00
-
Net Investing Cash Flow
20,361.00
96,424.00
205,262.00
29,358.00
37,576.00
Cash Dividends Paid - Total
6,051.00
12,102.00
18,153.00
6,051.00
7,866.00
Issuance/Reduction of Debt, Net
49,122.00
32,193.00
78,775.00
67,161.00
45,298.00
Net Financing Cash Flow
59,511.00
53,127.00
57,809.00
71,789.00
53,277.00
Net Change in Cash
7,701.00
101,093.00
85,030.00
2,005.00
28,876.00
Free Cash Flow
66,009.00
31,383.00
15,344.00
68,293.00
24,521.00
Net Assets from Acquisitions
-
-
160,436.00
-
-
Other Sources
-
120,089.00
1,300.00
-
-
Change in Capital Stock
-
-
-
1,423.00
113.00
Exchange Rate Effect
291.00
2,542.00
818.00
859.00
120.00
About Elos Medtech AB
View Profile
